Agile Therapeutics News - AGRX

Company Name	Stock Ticker Symbol	Market	Type
Agile Therapeutics Inc	AGRX	NASDAQ	Common Stock

	Price Change	Change Percent	Stock Price	Last Traded
	0.00	0.00%	0.6022	20:00:00

Open Price	Low Price	High Price	Close Price	Prev Close
			0.6022	0.6022

more quote information »

Recent News

Date	Time	Source	Heading
3/28/2024	08:05	GLOBE	Agile Therapeutics Reports Fourth Quarter & Full Year 2023..
3/25/2024	16:30	GLOBE	Agile Therapeutics Announces Delisting from Nasdaq
3/21/2024	06:35	GLOBE	Correction - Agile Therapeutics to Report Fourth Quarter and..
3/20/2024	08:15	GLOBE	Agile Therapeutics to Report Fourth Quarter and Full Year..
3/13/2024	07:31	GLOBE	Agile Therapeutics Completes Pay-off of Debt and Remains..
2/23/2024	16:57	EDGAR2	Form 424B5 - Prospectus [Rule 424(b)(5)]
2/23/2024	16:55	EDGAR2	Form 424B5 - Prospectus [Rule 424(b)(5)]
2/22/2024	09:01	GLOBE	Agile Therapeutics Announces Exercise of Warrants for $4.8..
2/15/2024	16:45	EDGAR2	Form 8-K - Current report
2/15/2024	16:30	GLOBE	Agile Therapeutics Announces Extension Granted by Nasdaq..
2/13/2024	20:02	EDGAR2	Form SC 13G/A - Statement of acquisition of beneficial..
2/07/2024	16:51	EDGAR2	Form S-1/A - General form for registration of securities..
2/06/2024	10:14	EDGAR2	Form SC 13G/A - Statement of acquisition of beneficial..
2/05/2024	09:21	EDGAR2	Form S-1/A - General form for registration of securities..
2/02/2024	16:27	EDGAR2	Form S-1/A - General form for registration of securities..
1/23/2024	09:29	GLOBE	The Biden-Harris Administration Announces New Guidance to..
12/20/2023	08:00	EDGAR2	Form S-1/A - General form for registration of securities..
12/12/2023	08:01	GLOBE	Agile Therapeutics Provides Update on Actions Being Taken to..
12/11/2023	17:30	EDGAR2	Form S-1 - General form for registration of securities under..
12/06/2023	08:00	EDGAR2	Form 8-K - Current report
12/04/2023	08:00	EDGAR2	Form 8-K - Current report
11/09/2023	16:30	EDGAR2	Form 10-Q - Quarterly report [Sections 13 or 15(d)]
11/09/2023	08:15	EDGAR2	Form 8-K - Current report
11/09/2023	08:05	GLOBE	Agile Therapeutics Reports Third Quarter 2023 Financial..
10/26/2023	08:05	GLOBE	Agile Therapeutics to Report Third Quarter 2023 Financial..
10/04/2023	16:45	EDGAR2	Form 4 - Statement of changes in beneficial ownership of..
10/04/2023	16:30	GLOBE	Agile Therapeutics Reports an Inducement Grant to New Chief..
10/02/2023	16:30	EDGAR2	Form 8-K - Current report
9/28/2023	16:50	EDGAR2	Form 8-K - Current report
9/05/2023	08:05	GLOBE	Agile Therapeutics to Present at the H.C. Wainwright 25th..
8/25/2023	16:02	EDGAR2	Form 3 - Initial statement of beneficial ownership of..
8/22/2023	08:30	EDGAR2	Form 8-K/A - Current report: [Amend]
8/09/2023	16:31	EDGAR2	Form 10-Q - Quarterly report [Sections 13 or 15(d)]
8/09/2023	08:10	EDGAR2	Form 8-K - Current report
8/09/2023	08:05	GLOBE	Agile Therapeutics Reports Second Quarter 2023 Financial..
7/26/2023	08:30	GLOBE	Agile Therapeutics to Report Second Quarter 2023 Financial..
6/30/2023	16:50	EDGAR2	Form 8-K - Current report
6/30/2023	16:38	EDGAR2	Form 4 - Statement of changes in beneficial ownership of..
6/30/2023	16:38	EDGAR2	Form 4 - Statement of changes in beneficial ownership of..
6/30/2023	16:37	EDGAR2	Form 4 - Statement of changes in beneficial ownership of..
6/30/2023	16:37	EDGAR2	Form 4 - Statement of changes in beneficial ownership of..
6/30/2023	16:36	EDGAR2	Form 4 - Statement of changes in beneficial ownership of..
6/26/2023	08:01	GLOBE	Agile Therapeutics Announces the Availability of Twirla® to..
6/23/2023	12:05	GLOBE	Agile Therapeutics Commends the Biden Administration’s..
6/15/2023	16:05	GLOBE	Agile Therapeutics Announces the Availability of Twirla®..
6/13/2023	16:05	GLOBE	Agile Therapeutics Announces New Agreement with vitaCare®..
5/25/2023	16:05	GLOBE	Agile Therapeutics Announces Closing of $7.5 Million Public..
5/22/2023	20:00	GLOBE	Agile Therapeutics Announces Pricing of $7.5 Million Public..
5/11/2023	16:05	GLOBE	Agile Therapeutics Reports First Quarter 2023 Financial..
5/08/2023	08:00	GLOBE	Agile Therapeutics to Report First Quarter 2023 Financial..